IP Group PLC
07 August 2026
|
FOR RELEASE ON |
7 August 2026 |
IP Group plc - Employee Share Schemes; Director/PDMR shareholding
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and technology companies with the potential to create a better future for all, announces the following in connection with its employee share schemes.
The Company has granted conditional share awards to the Group's executive directors, one other PDMR and selected other employees relating to the deferral of annual bonuses from the 2025 financial year and the grant of the 2026 Restricted Share Plan awards.
The Company was unable to make the awards in the usual window following the publication of its 2025 Annual Report and Accounts due to discussions with Railpen regarding a possible offer for the company at that time. Following the cessation of that restriction, the awards were granted on 5 August 2026 and consist of the following:
Deferral of annual bonuses relating to 2025 financial year
The below information relates to the deferral of a proportion of annual bonuses for the 2025 financial year until 2027 and 2028, in line with the Group's remuneration policy.
Deferred Bonus Awards
On 5 August 2026, IP Group granted conditional share awards over Shares to the Group's executive directors and one other PDMR under the IP Group Share Plan ("Share Plan"). The grants reflect the deferral of fifty per cent of each person's award above £25,000 under the Group's Annual Incentive Scheme in respect of the Group's performance for the financial year ended 31 December 2025. The following table sets out details of the relevant awards:
|
Name of Director/PDMR |
Structure of award |
Number of awards granted |
Total number of awards currently held |
|
Greg Smith |
Conditional Share Award |
160,858 |
246,511 |
|
David Baynes |
Conditional Share Award |
104,456 |
158,674 |
|
Mark Reilly |
Conditional Share Award |
66,860 |
133,866 |
|
Total |
332,174 |
539,051 |
Awards over a further 1,152,736 Shares were made to certain other of the Group's employees. As at the date of this announcement, a total of 2,303,972 Deferred Bonus awards over Shares remain outstanding under the Share Plan.
No consideration was paid for the grant of the awards and no consideration is due upon their release. Fifty per cent of the Deferred Bonus awards will be released on 31 March 2027 and fifty per cent on 31 March 2028, with each release generally subject to continued employment.
Long-term remuneration relating to 2026 and future financial years
The below information relates to long-term restricted share awards for the 2026 financial year and beyond, in line with the Group's remuneration policy.
Restricted Share Awards
On 5 August 2026, IP Group made restricted share awards under the Share Plan ("Restricted Share Awards") of 2,706,974 Shares to the Group's executive directors and one other PDMR.
Vesting of these Restricted Share Awards will take place over a three-year period commencing on 1 April 2026 and ending on 31 March 2029 (the "Vesting Period"), at which time the Remuneration Committee will determine the proportion of the award which will vest. This decision will be based on an assessment of performance against both a financial underpin based on adjusted NAV growth over the period of three financial years ending on 31 December 2028 and other qualitative performance measures (together the "Underpin Criteria").
The Restricted Share Awards made to the executive directors and one other PDMR are set out in the table below, and Restricted Share Awards over a further 2,841,014 Shares have been made to other Group employees. The number of Shares stated is the maximum number that could vest at the end of the Vesting Period for each executive director and PDMR. If the Committee considers that any of the Underpin Criteria is not met as part of its review at the end of the Vesting Period or there is otherwise reason to adjust the awards in accordance with the rules of the Share Plan, it will then consider whether it is appropriate to scale back the number of shares that vest.
The number of Restricted Share Awards made was calculated using the closing price on 4 August 2026 of 67.2p.
Subject to the Remuneration Committee's review of performance against the Underpin Criteria, the Restricted Share Awards will ordinarily vest on or around 31 March 2029. Any Restricted Share Awards which vest will ordinarily be subject to a post-vesting holding period of two years. Shares will be issued in connection with any vested Restricted Share Awards at the end of this holding period.
A copy of the Share Plan can be found at:
https://www.ipgroupplc.com/investors/corporate-governance
Shares in issue
As at 5 August 2026, the Company had 883,427,642 Shares in issue and no Shares held in treasury.
The following information is being disclosed pursuant to the requirements of MAR.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
DBA Awards
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||
|
a) |
Name |
Greg Smith |
||||||||||||
|
2 |
Reason for the notification |
|||||||||||||
|
a) |
Position/status |
Director Chief Executive Officer |
||||||||||||
|
b) |
Initial notification /Amendment |
Initial Notification |
||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||
|
a) |
Name |
IP Group plc |
||||||||||||
|
b) |
Legal Entity Identifier |
213800HG22UM138WFG43 |
||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc |
||||||||||||
|
b) |
Nature of the transaction |
Grant of conditional share awards under the IP Group plc Share Plan (DBA) |
||||||||||||
|
c) |
Currency |
GBP |
||||||||||||
|
d) |
Price(s) and volume(s) |
|
||||||||||||
|
e) |
Aggregated information -Aggregated volume - Price - Aggregated total |
Aggregated Number of Shares conditionally awarded to PDMRs on 5 August 2026: Price: £ nil 332,174 |
||||||||||||
|
f) |
Date of the transaction |
5 August 2026 |
||||||||||||
|
g) |
Place of the transaction |
Outside a trading venue |
||||||||||||
RSP Awards
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||||||
|
a) |
Name |
Greg Smith David Baynes Mark Reilly |
||||||||||||
|
2 |
Reason for the notification |
|||||||||||||
|
a) |
Position/status |
Director Chief Executive Officer |
||||||||||||
|
Initial notification /Amendment |
Initial Notification |
|||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||
|
a) |
Name |
IP Group plc |
||||||||||||
|
b) |
Legal Entity Identifier |
213800HG22UM138WFG43 |
||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 2p each in IP Group plc |
||||||||||||
|
b) |
Nature of the transaction |
Conditional award of Shares under the IP Group Share plan (RSP) |
||||||||||||
|
c) |
Currency |
GBP |
||||||||||||
|
d) |
Price(s) and volume(s) |
|
||||||||||||
|
e) |
Aggregated information -Aggregated volume - Price - Aggregated total |
Aggregated Number of Shares conditionally awarded to PDMRs on 5 August 2026: Price: £ nil 2,706,974 |
||||||||||||
|
f) |
Date of the transaction |
5 August 2026 |
||||||||||||
|
g) |
Place of the transaction |
Outside a trading venue |
||||||||||||
For more information, please contact:
|
IP Group plc |
|
|
Portland Alex Donaldson |
+44 (0) 7516 729702 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world's most exciting businesses in healthtech, deeptech and cleantech. Including through Parkwalk, the UK's largest growth EIS fund manager, we back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.